vs

Side-by-side financial comparison of American Outdoor Brands, Inc. (AOUT) and MEDIFAST INC (MED). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $57.2M, roughly 1.3× American Outdoor Brands, Inc.). On growth, American Outdoor Brands, Inc. posted the faster year-over-year revenue change (-5.0% vs -36.9%). MEDIFAST INC produced more free cash flow last quarter ($-6.6M vs $-14.1M). Over the past eight quarters, American Outdoor Brands, Inc.'s revenue compounded faster (3.5% CAGR vs -34.4%).

Deckers Outdoor Corporation, doing business as Deckers Brands, is an American footwear designer and distributor founded in 1973 and based in Goleta, California. The company's portfolio of brands includes UGG, Teva, and Hoka. It was founded by Doug Otto and Karl F. Lopker.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

AOUT vs MED — Head-to-Head

Bigger by revenue
MED
MED
1.3× larger
MED
$75.1M
$57.2M
AOUT
Growing faster (revenue YoY)
AOUT
AOUT
+31.9% gap
AOUT
-5.0%
-36.9%
MED
More free cash flow
MED
MED
$7.5M more FCF
MED
$-6.6M
$-14.1M
AOUT
Faster 2-yr revenue CAGR
AOUT
AOUT
Annualised
AOUT
3.5%
-34.4%
MED

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
AOUT
AOUT
MED
MED
Revenue
$57.2M
$75.1M
Net Profit
$2.1M
Gross Margin
45.6%
69.4%
Operating Margin
3.7%
-10.4%
Net Margin
3.6%
Revenue YoY
-5.0%
-36.9%
Net Profit YoY
-33.3%
EPS (diluted)
$0.16
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AOUT
AOUT
MED
MED
Q4 25
$57.2M
$75.1M
Q3 25
$29.7M
$89.4M
Q2 25
$61.9M
$105.6M
Q1 25
$58.5M
$115.7M
Q4 24
$60.2M
$119.0M
Q3 24
$41.6M
$140.2M
Q2 24
$46.3M
$168.6M
Q1 24
$53.4M
$174.7M
Net Profit
AOUT
AOUT
MED
MED
Q4 25
$2.1M
Q3 25
$-6.8M
$-2.3M
Q2 25
$-992.0K
$2.5M
Q1 25
$169.0K
$-772.0K
Q4 24
$3.1M
Q3 24
$-2.4M
$1.1M
Q2 24
$-5.3M
$-8.2M
Q1 24
$-2.9M
$8.3M
Gross Margin
AOUT
AOUT
MED
MED
Q4 25
45.6%
69.4%
Q3 25
46.7%
69.5%
Q2 25
40.9%
72.6%
Q1 25
44.7%
72.8%
Q4 24
48.0%
74.1%
Q3 24
45.4%
75.4%
Q2 24
41.9%
73.2%
Q1 24
42.7%
72.8%
Operating Margin
AOUT
AOUT
MED
MED
Q4 25
3.7%
-10.4%
Q3 25
-23.0%
-4.6%
Q2 25
-1.5%
-1.0%
Q1 25
0.5%
-1.1%
Q4 24
5.1%
0.6%
Q3 24
-6.2%
1.5%
Q2 24
-11.9%
-4.7%
Q1 24
-5.4%
4.5%
Net Margin
AOUT
AOUT
MED
MED
Q4 25
3.6%
Q3 25
-23.0%
-2.5%
Q2 25
-1.6%
2.3%
Q1 25
0.3%
-0.7%
Q4 24
5.2%
Q3 24
-5.7%
0.8%
Q2 24
-11.5%
-4.8%
Q1 24
-5.4%
4.8%
EPS (diluted)
AOUT
AOUT
MED
MED
Q4 25
$0.16
$-1.64
Q3 25
$-0.54
$-0.21
Q2 25
$-0.08
$0.22
Q1 25
$0.01
$-0.07
Q4 24
$0.24
$0.08
Q3 24
$-0.18
$0.10
Q2 24
$-0.41
$-0.75
Q1 24
$-0.23
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AOUT
AOUT
MED
MED
Cash + ST InvestmentsLiquidity on hand
$3.1M
$167.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$170.4M
$198.9M
Total Assets
$240.9M
$248.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AOUT
AOUT
MED
MED
Q4 25
$3.1M
$167.3M
Q3 25
$17.8M
$173.5M
Q2 25
$23.4M
$162.7M
Q1 25
$17.1M
$164.6M
Q4 24
$14.2M
$162.3M
Q3 24
$23.5M
$170.0M
Q2 24
$29.7M
$163.5M
Q1 24
$15.9M
$156.4M
Stockholders' Equity
AOUT
AOUT
MED
MED
Q4 25
$170.4M
$198.9M
Q3 25
$167.8M
$214.7M
Q2 25
$177.6M
$216.0M
Q1 25
$178.7M
$211.0M
Q4 24
$178.9M
$210.1M
Q3 24
$175.7M
$207.3M
Q2 24
$177.9M
$205.3M
Q1 24
$182.4M
$211.0M
Total Assets
AOUT
AOUT
MED
MED
Q4 25
$240.9M
$248.0M
Q3 25
$241.9M
$268.2M
Q2 25
$246.4M
$269.3M
Q1 25
$245.9M
$280.0M
Q4 24
$254.1M
$284.2M
Q3 24
$244.8M
$291.2M
Q2 24
$240.6M
$293.5M
Q1 24
$239.1M
$302.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AOUT
AOUT
MED
MED
Operating Cash FlowLast quarter
$-13.3M
$-5.3M
Free Cash FlowOCF − Capex
$-14.1M
$-6.6M
FCF MarginFCF / Revenue
-24.6%
-8.8%
Capex IntensityCapex / Revenue
1.3%
1.8%
Cash ConversionOCF / Net Profit
-6.41×
TTM Free Cash FlowTrailing 4 quarters
$-4.7M
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AOUT
AOUT
MED
MED
Q4 25
$-13.3M
$-5.3M
Q3 25
$-1.7M
$12.1M
Q2 25
$7.8M
$-3.4M
Q1 25
$5.9M
$3.4M
Q4 24
$-7.9M
$-4.9M
Q3 24
$-4.4M
$9.1M
Q2 24
$14.7M
$13.1M
Q1 24
$13.0M
$7.3M
Free Cash Flow
AOUT
AOUT
MED
MED
Q4 25
$-14.1M
$-6.6M
Q3 25
$-2.0M
$10.8M
Q2 25
$7.2M
$-4.8M
Q1 25
$4.2M
$1.9M
Q4 24
$-8.0M
$-7.2M
Q3 24
$-5.2M
$7.7M
Q2 24
$14.2M
$11.1M
Q1 24
$9.7M
$5.4M
FCF Margin
AOUT
AOUT
MED
MED
Q4 25
-24.6%
-8.8%
Q3 25
-6.7%
12.0%
Q2 25
11.6%
-4.5%
Q1 25
7.2%
1.6%
Q4 24
-13.3%
-6.1%
Q3 24
-12.5%
5.5%
Q2 24
30.6%
6.6%
Q1 24
18.2%
3.1%
Capex Intensity
AOUT
AOUT
MED
MED
Q4 25
1.3%
1.8%
Q3 25
1.0%
1.5%
Q2 25
0.9%
1.3%
Q1 25
2.9%
1.3%
Q4 24
0.1%
1.9%
Q3 24
2.0%
1.0%
Q2 24
1.1%
1.1%
Q1 24
6.2%
1.1%
Cash Conversion
AOUT
AOUT
MED
MED
Q4 25
-6.41×
Q3 25
Q2 25
-1.36×
Q1 25
34.86×
Q4 24
-2.55×
Q3 24
8.04×
Q2 24
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AOUT
AOUT

Traditional Channels Net Sales$36.8M64%
E Commerce Channels Net Sales$20.4M36%

MED
MED

Segment breakdown not available.

Related Comparisons